1
|
Capeding TPJ, Rosa JD, Lam H, Gaviola DG, Garfin AMC, Hontiveros C, Cunnama L, Laurence YV, Kitson N, Vassall A, Sweeney S, Garcia-Baena I. Cost of TB prevention and treatment in the Philippines in 2017. Int J Tuberc Lung Dis 2022; 26:392-398. [PMID: 35505478 PMCID: PMC9067429 DOI: 10.5588/ijtld.21.0622] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
Abstract
BACKGROUND: The Philippines aims to accelerate TB reduction through the provision of universally accessible and affordable services. The objectives of this paper are to estimate the costs of TB services and interventions using a health systems´ perspective, and to explore cost differences in service delivery via primary care facilities or hospitals.METHODS: Data were collected from a multi-stage stratified random sampling of 28 facilities in accordance with Global Health Cost Consortium costing standards and analysis tools. Unit costs (in US$) estimated using top-down (TD) and bottom-up (BU) approaches, are summarised following Value TB reporting standards and by broad facility type.RESULTS: Cost of delivering 32 TB services and eight interventions varied by costing method and delivery platform. Average BU costs ranged from US$0.38 for treatment support visits, US$2.5 for BCG vaccination, US$19.48 for the Xpert® MTB/RIF test to US$3,677 for MDR-TB treatment using the long regimen. Delivering TB care in hospitals was generally more costly than in primary care facilities, except for TB prevention in children and MDR-TB treatment using the long regimen.CONCLUSION: Comprehensive costing data for TB care in the Philippines are now available to aid in the design, planning, and prioritisation of delivery models to End TB.
Collapse
Affiliation(s)
- T. P. J. Capeding
- Institute of Health Policy and Development Studies, National Institutes of Health, University of the Philippines Manila, Manila, Philippines
| | - J. D. Rosa
- Institute of Health Policy and Development Studies, National Institutes of Health, University of the Philippines Manila, Manila, Philippines
| | - H. Lam
- Institute of Health Policy and Development Studies, National Institutes of Health, University of the Philippines Manila, Manila, Philippines
| | - D. G. Gaviola
- Department of Health, National TB Control Programme, Manila, Philippines
| | - A. M. C. Garfin
- Department of Health, National TB Control Programme, Manila, Philippines
| | - C. Hontiveros
- Department of Health, National TB Control Programme, Manila, Philippines
| | - L. Cunnama
- Health Economics Unit & Health Economics Division, University of Cape Town, Cape Town, South Africa
| | - Y. V. Laurence
- Department of Global Health and Development, Centre for Health Economics in London, London School of Hygiene & Tropical Medicine, London, UK
| | - N. Kitson
- Department of Global Health and Development, Centre for Health Economics in London, London School of Hygiene & Tropical Medicine, London, UK
| | - A. Vassall
- Department of Global Health and Development, Centre for Health Economics in London, London School of Hygiene & Tropical Medicine, London, UK
| | - S. Sweeney
- Department of Global Health and Development, Centre for Health Economics in London, London School of Hygiene & Tropical Medicine, London, UK
| | - I. Garcia-Baena
- Global TB Programme, World Health Organization, Geneva, Switzerland
| |
Collapse
|